Benitec Biopharma
BNTC
$8.87
Share price
7.89%
Change (1 day)
4,334.30%
Change (1 year)
Operating Margin for Benitec Biopharma (BNTC)
Operating Margin as of May 2024 (TTM): -24,942.50%
According to Benitec Biopharma 's latest financial reports and stock price the company's current Operating Margin is -24,942.50%. At the end of 2022 the company had an Operating Margin of -24,942.47%.
Operating Margin history for Benitec Biopharma from 2015 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -24,942.47% | 6.01% |
| 2021 | -23,528.81% | 175.84% |
| 2020 | -8,529.90% | -33767.47% |
| 2019 | 25.34% | -101.35% |
| 2018 | -1,877.42% | 93.35% |
| 2017 | -970.99% | -81.82% |
| 2016 | -5,340.09% | 401.58% |
| 2015 | -1,064.66% | 0% |
| 2014 | -1,064.66% | -15.03% |
| 2013 | -1,253.01% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | -234,760.00% | 841.20% | Bahamas |
 NRC Health
NRC | 32.86% | -100.13% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.